Tag Archives: PNRA

Best Small Cap Stocks To Buy Right Now

Small cap oil and gas stock Stone Energy Corporation (NYSE: SGY) is the most shorted stock on the NYSE with short interest of 59.78% according toHighshortinterest.com. Stone Energy Corporation is an independent oil and natural gas exploration and production company headquartered in Lafayette, Louisiana whosbusiness strategy is to leverage high cash flow generated from existing assets to:


Top Small Cap Stocks To Invest In Right Now

The Q3 2016 earnings report for small cap chip stock Advanced Micro Devices, Inc (NASDAQ: AMD)is scheduled for after the market closes onThursday (October 20th). Wehad AMDin our SmallCap Network Elite Opportunity (SCN EO) portfolioon and off for the past couple of yearswith the last time being as aspeculative takeover candidatedue to itstechnology portfolio. However, Advanced Micro Deviceshas continued....More>>>

Hot Small Cap Stocks To Invest In Right Now

The Q4 2016 earnings report for small cap New York City based burger stock Shake Shack Inc (NYSE: SHAK) is scheduled for after the market closes onWednesday (March 1st). Shake Shack did have a sizzling IPO back in January 2015, but there was also talk ofpeak burger given the Habit Restaurants Inc (NASDAQ: HABT) IPO around the same time and the presence of other burger stocks. Buckinghams John Zolidis....More>>>

Hot Warren Buffett Stocks To Invest In Right Now

My investment thesis on American Airlines Group (NASDAQ:AAL) for a while now has suggested the market was overlooking the new profit focus on the airline. The theory was further backed by the recent large-scale investments by Berkshire Hathaway (NYSE:BRK.B) and backed by Warren Buffett.

The stock though has struggled to gain much traction since the peak back in 2015. Is the market so....More>>>

Top 10 Small Cap Stocks To Watch Right Now

My Top Pick for 2017 is a clinical-stage biopharmaceutical company involved in the treatment of neurodegenerative diseases, explains small cap expert Tom Bishop, editor BI Research.

The lead drug from Anavex Life Sciences (AVXL) — called Anavex 2-73 — has just reported very promising phase 2a results in Alzheimer’s patients at the annual CTAD conference.